Even though the mechanisms by which EFEMP-1 might contribute to AMD is not known, based upon the cancer studies, it is reasonable to speculate that numerous downstream pathways are activated by increased EFEMP-1 levels. The gene discussed is EFEMP1; the disease is age-related macular degeneration.